Sorry, we need to turn on JavaScript. Please turn it on
HOME
ABOUT US
Company Profile
Management Team
Corporate Culture
SAB
Milestones
R & D
Pipeline
Areas of Focus
Strategy
NEWS CENTER
News Center
PARTNERS
Partners
INVESTORS
Investors
CAREERS
Join Us
Employee Benefits
CONTACT
Contact
中文
|
EN
NEWS
News Center
06
2026.05
National Investigator Meeting for Onradivir Granules/Tablets Phase III Clinical Studies in Children and Adolescents with Influenza A Successfully Concluded
06
2026.05
Responding to "National Weight Management Year," Contributing to Healthy China! Raynovent's RAY1225 Injection Phase III Clinical Study Successfully Achieves Full Subject Enrollment Milestone
06
2026.05
RAY1225 Injection Phase III Clinical Trials National Investigator Meeting Successfully Held: Embarking on a New Journey in Obesity and Diabetes Treatment
06
2026.05
Gathering Momentum and Setting Sail! Successful Protocol Discussion Meeting Held for Onradivir Tablets Phase III Trial in Adolescents with Influenza A
06
2026.05
Riding the Momentum! Successful Protocol Discussion Meeting Held for Onradivir Granules Phase III Trial in Pediatric Influenza A
1
2
3
4
5
6